Uganda Begins Ebola Vaccine Trial for Bundibugyo Strain in Masaka

The town of Masaka in southern Uganda is conducting a Phase 1 trial of a vaccine candidate against the Bundibugyo strain of the Ebola virus, which is circulating in the region. There is currently no approved treatment or vaccine for this particular strain, making the trial a significant step in the response. France 24 English reports on the launch of the trial and the effort to develop protection against a virus variant that has lacked approved medical countermeasures. The Phase 1 stage typically focuses on establishing safety and immune response in a small group of volunteers. The report highlights the public health stakes for Uganda and the region as health authorities and researchers work to close a gap in Ebola preparedness for the Bundibugyo strain.